Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Helen Colhoun Added: 1 year ago
EASD 24 - We are joined by Dr Helen Coulhoun (University of Edinburgh, UK) to discuss the key findings of a prespecified analysis of the SELECT trial, which investigated the effectiveness of semaglutide in reducing major cardiac events in the presence of impaired kidney function in patients with overweight and obesity.Findings showed that participants in the study with reduced eGFR and/or… View more
Added: 1 month ago Source:  Radcliffe Cardiology
Frailty is a common and significant factor associated with adverse outcomes in patients with heart failure, but the prognostic utility of simple assessment tools in contemporary practice remains an area of investigation. A new study using data from a large Japanese registry has found that the Clinical Frailty Scale (CFS) effectively captures both physical and cognitive decline and is an… View more
Jessica Spence is an anesthesiologist and ICU fellow who is completing a PhD under the supervision of Dr. PJ Devereaux. She is a perioperative research fellow at PHRI whose research program focusses on the cognitive and functional outcomes of cardiac and non-cardiac surgery. View more
Job title: Professor of Medicine and an Associate Director of the Clinical and Translational Research Center/Clinical and Translational Science Award (CTSA)
Job title: Assistant Professor of Medicine and Director of Clinical Hypertension Programs
Augusto Vicario is Clinical Cardiologist, graduated in Buenos Aires University and postgraduate in the El Salvador University, was Past President of the Buenos Aires Society of Cardiology (Argentine Federation of Cardiology) and Director of the “Heart and Brain Study”, a National Register of Cognitive Status in hypertensive patients. Today, he is full member of the Argentine Federation of… View more
Research Area(s) / Expertise:

Cardio-oncology

Job title: Medical Director, Survivorship Program
A Genitourinary Medical Oncologist at the Dana-Farber Cancer Institute, Alicia Morgans serves as the Medical Director of the Survivorship Program. She is an experienced clinician and researcher with knowledge of patient-reported outcomes, clinical trials, and incorporating patient preferences and beliefs into therapeutic decision-making. Her studies have looked into the skeletal, cardiovascular,… View more